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Influence of Gut Microbiota on 
Behavior and Its Disturbances
Valentina Ignatova
Abstract
Hippocrates statement that “All disease begins in the gut” continues to be up 
to date more than 2000 years later. Growing number of scientific reports focus on 
the important role of intestinal microorganisms for modulation of many systems 
and human behavior. As a key component of the gut brain, gut microbiota influ-
ences the development and maturation of the hypothalamic-pituitary-adrenal 
axis, affects the development and function of the immune system, regulates the 
blood-brain barrier, modulates the synthesis and recognition of neurotransmitters, 
regulates neurogenesis, formation of myelination and supports the development 
and function of the brain. Disruption of gut-brain axis function is associated with 
alterations in the stress response and might contribute to neuropsychiatric diseases 
as depression, autistic spectrum disorders, rapid eye movement sleep behavior 
disorder, Parkinson disease, Alzheimer disease and other mental conditions. Studies 
in animal models are crucial for guiding research on brain-gut-microbiome axis in 
humans, as the impact of microbiota on specific brain regions and aspects of animal 
behavior will help in the selection of tasks for cognitive assessment. Exploring 
the interaction of gut microbes and human brain will not only allow us to better 
understand the pathogenesis of neuropsychiatric disorders, but will also provide us 
new opportunities for the design of novel immuno- or microbe-based therapies.
Keywords: gut microbiota, brain, gut-brain axis, behavior disturbances,  
modulation, human behavior, animal models
1. Introduction
Hippocrates statement that “All disease begins in the gut” continues to be up to 
date more than 2000 years later. The fields of microbiology, gastroenterology and 
neuroscience have evolved gradually over time and remarkable progress in modern 
medicine has been achieved not only in their individual trajectories, but also in their 
active interaction. It has recently become evident that gut bacterial flora can greatly 
influence all aspects of physiology, including gut-brain communication, brain func-
tion and even behavior [1].
The population of microorganisms, localized in the human gut and consisting 
of bacteria, viruses, protozoa, fungi etc., definitely exceeds the number of cells that 
make up the human body. The collection of these microorganisms, their genomes 
and the factors that they produce are all part of the gut microbiome [2, 3]. The role 
of microorganisms that make up the intestinal flora can be identified as patho-
genic, neutral, or useful for the host. The beneficial bacteria known as probiotic 
bacteria predominate in the intestine of healthy subjects. The word probiotic has 
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Greek origin and its meaning states “for life”. In fact, probiotics are referred to live 
microbes which are important for maintaining the intestinal microbial balance and 
have the capacity to keep and improve the health of their human host” [4–6].
The intestinal microbiota and its metabolites influence modulation of gastro-
intestinal (GI) functions through their ability to affect gut permeability, mucosal 
immune function, intestinal motility and sensitivity, and also activity of the enteric 
nervous system (ENS) [6, 7]. Multiple mechanisms, including endocrine and neu-
rocrine pathways, are suggested to be involved in gut microbiota-brain signaling. 
On the other hand, the brain can in turn alter microbial composition and behavior 
via the autonomic nervous system (ANS) [8].
Evidences from studies in rodents raised in a germ-free (GF) setting pointed 
that the gut microbiota influences the development of emotional behavior, 
stress- and pain-modulation systems and brain neurotransmitter systems. 
Furthermore, perturbations of microbiota occurring as a result of probiotics and 
antibiotics application exert lead to effects on some of these modalities in adult 
animals [8–11].
The absence of micro-organisms in the gastrointestinal tract (GIT) of mice 
shows a reduction in the number of Peyer’s patches and IgA producing B-cells in 
the lamina propria versus healthy controls, whereas the introduction of microbes 
reverses these effects [12, 13]. It is curious that, GF mice also provide evidence of an 
overactive hypothalamic-pituitary-adrenal (HPA) axis and reduced monoaminergic 
activity, suggesting that microbial colonization can have lasting effects on central 
systems, which are involved in the psychopathology of depression [14].
Some of the most common species/probiotics are bifidobacteria. Shortly after 
birth, up to 90% of the bacteria found in children’s GIT are bifidobacteria, and in 
adults they still account for approximately 3–5% of the microflora [15]. Moreover, 
in inflammatory diseases such as irritable bowel syndrome (IBS), treatment with 
bifidobacteria normalizes the existing disequilibrium between pro-inflammatory 
and anti-inflammatory cytokines in this disease [16, 17]. Based on the established 
important role of the balance between anti- and pro-inflammatory cytokines in the 
pathophysiology of depression [18, 19], it can be hypothesized that probiotics may 
have potential antidepressant properties. Of course, the potential benefits of probi-
otics as adjuvant therapy in depression are currently being discussed [20]. A recent 
study of Benton et al. has demonstrated a beneficial effect of long-term probiotic 
treatment on the mood of healthy subjects [5, 21].
It is supposed, that the violation of the two-way functional connection between 
brain and gut microbiota take a part in the pathogenesis of certain diseases of “gut-
brain-axis” such as IBS and impairments of GI-functionality [1, 22] but it could be 
also involved in the pathogenesis of a lot of significant neuropsychiatric diseases: 
autism spectrum disorders (ASDs) [1, 23], Parkinson’s disease [24], mood disorders 
[25]; and chronic pain conditions [1, 5, 26].
Unfortunately, the information how these findings could be transferred to 
healthy humans or to disease states involving the brain or the gut-brain axis is still 
insufficient. Further research with focus on this topic for translation to human 
physiology and to diseases such as irritable bowel syndrome, autism, anxiety, 
depression, and Parkinson’s disease should be performed [8].
The interaction between gut microbiota and brain at the levels of gut-brain axis 
and their influence on manifestation of gastrointestinal, mental and neuropsychiat-
ric diseases is presented at Figure 1.
The aim of the review is to examine the dependence between the functioning of 
microbiota-gut-brain axis and human behavior and how it can contribute to a better 
understanding of human psychology and choosing an appropriate therapeutic 
approach in cases of behavior disturbances.
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2. Method of searching
An advanced search was performed in electronic database (PubMed, 
MEDLINE), based on the combinations of the following key words and phrases 
as entry screening criteria: “gut microbiota”, “brain”, “behavior disturbances”, 
“modulation”, “microbiota-gut-brain axis”, “influence of gut microbiota on human 
behavior”, “abruption of microbiota-gut-brain axis”, “animal models of interrupted 
microbiota-gut-brain axis”. The time period of the search was unlimited. The 
relevant information was selected from systematic reviews, meta-analysis, books 
chapters, original articles, conference abstracts and theses, published in English. 
The exclusion criteria targeted case reports which were not entered in the analysis. 
The reference of the related scientific sources from the selected articles was addi-
tionally checked and the relevant of them were also included in the recent work. 
A relationship between functioning of intestinal microbiota and human behavior 
was searched. Based on the above listed criteria, initially were retrieved 3 books, 
Figure 1. 
Bidirectional interactions between gut microbiota and brain. Relationship with medical conditions [27].
Figure 2. 
Method of searching.
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60 scientific reviews, 98 original articles, 3 abstracts. The final number of selected 
and really used scientific works was as follows: 3 book chapter, 57 scientific reviews, 
94 research studies, 2 paper abstracts on the current topic “Influence of gut micro-
biota on behavior and its disturbances”—Figure 2. The chronology of knowledge 
regarding microbiota-gut-brain axis and its influence on human behavior was also 
tracked. The similarities of points of view and results, as well as the contradictions 
in published literature were analyzed. The possibilities for psychological and drug 
interventions in patients with behavior disturbances based on the summarized 
conclusions were also highlighted.
3. Role of gut-brain axis for mental health
The essential interaction between the gut and the brain through the gut-brain 
axis is well established. The environment and related factors render influence 
on central nervous system (CNS), as well as on HPA axis. Furthermore, the CNS 
interacting with the ENS, the intestinal muscular and mucosal layers via vegetative 
afferent and efferent tracts, modulates gut functions as permeability, mucus secre-
tion, motility, as well as host immunity [13, 28, 29]. Thus, CNS inputs can affect 
the gut functions, while gut inputs could modify specific CNS processes [1, 30]. 
Interruption of these bidirectional interactions may provoke neuroinflammation 
processes and could be involved in the pathogenic ways responsible for develop-
ment of CNS disorders [13].
3.1 Anatomy of the gut-brain axis
The functioning of the colon is modulated by both internal (intrinsic) and 
external (extrinsic) neural pathways [31].
3.1.1 Intrinsic innervation
The ENS is integrative system of neurons with structural complexity and 
functional heterogeneity, similar to these of brain and spinal cord. Its main role is to 
control motility, secretion, mucosal transport and blood flow of the GIT [32]. The 
ENS realizes these functions via motor neurons, localized in ganglia, composing a 
final common pathway to the effector cells of the GIT. Although these specialized 
motor neurons receive some impulses from CNS through parasympathetic and 
sympathetic pathways, their function is predominantly coordinated by sensory 
neurons and interneurons localized within the ENS [30].
3.1.2 Extrinsic innervation
3.1.2.1 Splanchnic “sympathetic” nerves
Their noradrenergic fibers within the wall of the GI tract arise from cell bod-
ies embedded in the prevertebral sympathetic ganglia. The major “sympathetic” 
projections to the large intestine originate from the inferior mesenterial ganglia and 
the remaining noradrenergic fibers to the rectum are provided by the pelvic ganglia.
3.1.2.2 Vagal (parasympathetic) innervation
The vagal nerve transfers information between the internal organs and the brain-
stem. It contains both afferent and efferent nerve fibers and innervates the entire 
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gut with exception of the distal third of the colon. Vagal afferents terminate in the 
nucleus of the solitary tract (NTS) whose impulses go up through the parabrachial 
nucleus (PBN) to the thalamus, limbic system and insula [33, 34]. Spinal fibers pass 
up via the spinothalamic tract and the dorsal spine columns. Respectively, the spi-
nothalamic pathway goes ascendingly to the thalamus, and the dorsal columns give 
projections to the gracile nucleus and cuneate nucleus in the upper medulla. Efferent 
impulses from the last rostral medullar structures reach the thalamus through the 
medial lemniscus. In turn, thalamic projections ascend to the primary somatosensory 
cortex and insula [30]. Vagus motor nuclei are represented by nucleus ambiguus 
(NA) and dorsal motor nucleus (DMN). The DMN is a source of efferents to the 
smooth muscles of the gut that form synapses with the neurons of the MP [7, 33].
3.2 Gut microbiota influences and human brain function
3.2.1 ANS modulation of the gut microbial environment
Impaired intestinal transit caused by compromised migratory motor complexes 
(under parasympathetic modulation) is associated with an increased microbial 
colonization in the small intestine [5, 35–37]. The frequency of regular migrating 
motor complex is influenced by the number of feeds, quality of sleep and stress. 
Acute stress is associated with increased parasympathetic output to the small and 
large intestine and decreased vagal output to the stomach [38]. ANS affects the 
mechanisms of immune activation at the level of intestinal epithelium. This pro-
cess could be influenced trough modulation of the intestinal immune cells such as 
macrophages and mast cells against gut luminal microbes through antimicrobial 
peptides or indirectly via changing the access of gut microbiota to the intestinal 
immune cells [1, 39]. This process could be influenced trough modulation of the 
intestinal immune cells such as macrophages and mast cells against gut luminal 
microbes through antimicrobial peptides or indirectly via changing the access of gut 
microbiota to the intestinal immune cells.
Preclinical studies proved that increased permeability of intestinal epithelium 
after exposure to different stressors is result of easier translocation of gut micro-
biota followed by driving of immune response [1, 40, 41].
3.2.2 Effects of host’s signal molecules on the function of the intestinal microbiota
Neuronal and neuroendocrine signaling molecules as catecholamines, serotonin, 
cytokines, GABA, dinorphine, etc. dispersed into the gut lumen through neurons, 
immune and enterochromaffin cells can also play a role in the modification of 
intestinal environment [1, 8, 42], probably regulated by the CNS [43]. Many stress 
factors result to increasing of both plasma and luminal gut levels of catecholamines 
as norepinephrine [8, 44]. In vitro experiments indicated that some pathogen 
microbes could change their proliferative ability after exposition to exogenous 
catecholamines. Norepinephrine may accelerate the proliferation of several strains 
of intestinal pathogenic microorganisms and could increase the virulence of 
Campylobacter jejuni [1, 45, 46].
3.2.3 Microbe-to-host signaling by microbial signaling molecules
Metabolites produced by intestinal microbiota, including short chain fatty acids 
(SCFAs), bile acid metabolites and neuroactive agents such as GABA, tryptophan 
precursors and metabolites, serotonin and catecholamines, including free metabo-
lites and cytokines released during the immune response to microbes may deliver 
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the signal to the host via local cell receptors in the intestine [37, 47]. These factors 
can also give signals via neurokines through afferent vagal and spinal pathways and 
endocrine mechanisms to target non-GI tracts, including vagal afferents in the por-
tal vein and receptors in the brain. A significant part of the metabolites identified 
in the circulation are with intestinal microbial origin [48, 49]. The enteroendocrine 
cells, as well as the neurons forming the submucosal and myenteric ganglia, express 
different types of SCFA receptors [50] A diet that includes Bifidobacterium breve 
leads to elevated levels of fatty acids in the brain, but unfortunately there is not a 
clear explanation for that mechanism [1].
Actual studies confirm that multiple nuclear receptors (NRs) are expressed 
in the GI tract and several microbe-produced metabolites act as ligands of NRs. 
Intestinal bacteria secrete metabolites including indole derivatives, hormones and 
secondary BAs, which play role of natural ligands for the host’s NRs [51]. In this 
way the microbial metabolites can realize biological effects in the human body via 
regulation of the host’s gene expression. These dynamic interactions permit overall 
control on the health or disease development in the host through direct effect of the 
microbiota on the human physiology [11]. Via signaling to the brain, the microbiota 
regulates metabolism, CNS development, inflammation as well as mood and behav-
ior. It is essential that the human host has the ability to voluntarily influence and 
meliorate its own microbiota through nutritional or probiotic interventions [52].
Latest research found that, in the presence of the microbiota, the intestinal 
epithelial lining generates physiological levels of oxidative stress. On the other 
hand, these interfere both with the composition and functionality of the microbiota 
(e.g., anaerobes thrive in the presence of electron acceptors) and directly with the 
gut permeability. This lead to increased probability of xenobiotic molecules to reach 
the systemic circulation as well as the CNS [53].
Another well-known interaction between the microbiota and CNS involves 
astrocytes. Astrocytes represent a functionally diverse group of glial cells, which are 
responsible for ion homeostasis, neurotransmitter balance, storage of glycogen, the 
integrity of the blood brain barrier (BBB), realizing of the neuronal signaling, which 
play a main role in the neuroinflammation process [54]. The inflammation could be 
suppressed by modulation of type I interferon signaling in astrocytes, initiated by 
microbial metabolite products, which activate the aryl hydrocarbon receptors (AhRs), 
The indoles, released from gut microbiota, act as AhR agonists [55]. The dietary 
tryptophan in intestinal cavity, which is undigested, is transformed into indole in the 
presence of the microbial enzyme tryptophanase. Then the indoles could be modified 
through microbial or viler enzymes to indole derivate with various affinity [10, 56].
4.  Dysregulation of the gut-brain axis. Evidences from experiments on 
animals
Alterations in the microbial contain of the GIT are considered to contribute to 
inflammatory and functional bowel disorders and psychiatric comorbidities. The 
results of recent studies using various strains of mice and rats, various strains of 
probiotics and various experimental paradigms reported a number of microbial 
bowel modulation effects in emotional behavior [57–59], learning and memory 
[60], social interactions [61] and nutritional behavior [62].
4.1 Experiments on mood changes in disturbed gut-microbiota in rats
The first experiments in young GF mice which confirmed the influences of 
gut microbiota on postnatal development of the hypothalamic-pituitary response 
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to stress were performed by Sudo et al. in 2004. It is interesting, that the GF mice 
expressed reduced anxiety-like behavior in the elevated plus maze (EPM), a reliable 
behavioral test that examines approach and avoidance behavior in mice, compared 
to specific pathogen free (SPF) mice [63].
Desbonnet et al. evaluated the potential antidepressant properties of probiotics 
through testing of rats chronically treated with Bifidobacteria infantis in the forced 
swim test [5]. Probiotic administration in naive rats had no effect on swimming 
behaviors. However mitogen stimulation in probiotic treated rats lead to substantial 
reduction of IFN-γ, TNF-α and IL-6 cytokines compared to controls (p < 0.05). In 
addition, the plasma concentrations of tryptophan (p < 0.005) and kynurenic acid 
(p < 0.05) were significantly elevated in the rats, treated with bifidobacteria [20]. 
Treatments with Bifidobacteria also lead to reduced 5-HIAA concentration in the 
frontal cortex and a decrease in DOPAC in the amygdaloid cortex [5].
Schroeder et al. provided evidences for production of benzodiazepine ligands in 
a rat model of encephalopathy or butyrate acting as a histone D-acetylesterase that 
was shown to have an antidepressant effect [64, 65].
The study of Arseneault-Breard et al. gave the first evidences for beneficial effect of 
probiotics L. helveticus R0052 and B. longum R0175 on post-myocardial infarct depression 
in rats. This positive probiotic influence was engaged in maintaining of the gut barrier 
integrity, which is possibly associated with the host’ inflammatory state after MI [84].
The association of increased HPA axis responses and reduced anxiety-like 
behaviors observed in several of the studies performed in GF mice suggests that 
HPA axis and nonhypothalamic (anxiety-like behavior) components of central 
stress circuits may be affected on different ways according to the GF conditions, 
depending on species and mouse strain. These findings suggest that the increased 
HPA axis activity in GF animals may represent a response of the organism to the 
loss of microbiota-related energy sources [8].
Savignac et al. demonstrated that the two Bifidobacterium strains used in their 
study were able to improve the anxious phenotype of innately anxious BALB/c mice 
in a strain-specific manner and the effect was better than that from the admin-
istered antidepressant escitalopram. These findings support the statement that 
probiotics could be a reliable alternative for treatment of mood disorders [142].
Figure 3. 
Impact of gut microbiota and external stress factors on behavior [66].
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On Figure 3 is presented influence of both gut microbiota and external stressors 
on behavior.
4.2 Experiments on behavior changes in disturbed gut-microbiota in rats
The increased hippocampal brain-derived neurotropic factor (BDNF) registered 
in the ATM-treated mice is corresponding with their gregarious behavior. A recent 
study found increased BDNF expression in the amygdala during fear learning  
[67, 68]. Over activation of the amygdala also has been implicated in depression and 
anxiety [67, 69]. Lower levels of BDNF in the amygdala of ATM treated mice were 
associated with increased exploratory behavior.
Bercik et al. found that SPF mice who received antimicrobial agents per os 
demonstrated enhanced exploratory behavior and hippocampal expression of 
BDNF. This finding was associated with temporary alteration of the representa-
tives of their microbiota and was not accompanied by inflammatory status, altera-
tion of gastrointestinal neurotransmitters levels, nor with vagal or sympathetic 
function. Intraperitoneal application of antimicrobial agents to SPF mice, similar 
to their oral administration in GF mice had no influence on behavior. Increased 
exploratory behavior and high hippocampal levels of BDNF were reported in GF 
BALB/c mice, colonized with microbiota from NIH Swiss mice. Suppression of 
exploratory behavior was demonstrated in GF NIH Swiss mice, colonized with 
BALB/c microbiota [2, 70].
The study of Bercik et al. did not provide proof for intestinal inflammation, as 
oppose to Verdú et al.’ investigation [71], where administration of ATMs in a higher 
dose and for a longer period was made in NIH Swiss mice. In the Bercik’s experi-
ment embarrassment of the intestinal microbes did not change myeloperoxidase 
activity, histology or cytokine profile of the colon [8]. No differences in serotonin, 
dopamine, or noradrenaline content in the gut of ATM-al. treated mice were 
observed, suggesting that these neurotransmitters are not involved in mediating the 
behavioral changes observed in the model.
Li et al. and Bercik et al. reached similar results on memory and learning skills 
in adult mice [11], applying different nutritional supplements to animals at a very 
early age with the following disruption of the intestinal flora in very young age. 
Working and referred memory was better in the animals on rich in beef diet as 
opposed to the mice on standard meal [8].
Neufeld et al. supposed that the low anxiety-like phenotype was accompa-
nied by long-term changes in plasticity-related genes in the hippocampus and 
amygdala. They found altered GF behavior, accompanied by a decrease in the 
N-methyl-D-aspartate receptor subunit NR2B mRNA expression in the central 
amygdala, increased BDNF expression and decreased serotonin receptor 1A 
(5HT1A) expression in the dentate granule layer of the hippocampus. It is the first 
work which demonstrated an altered behavioral phenotype related with lack of 
gut microbiota [59].
In their work Bravo et al. registered increased levels of GABAB1b mRNA in cin-
gular and prelimbic areas in mice treated for a long time with L. rhamnosus (JB-1), 
while the concentration of these neurotransmitters was reduced in the hippocampus, 
amygdala and locus coeruleus in the same experimental animals. Furthermore, the 
GABAAα2 level was reduced in the prefrontal cortex and amygdala, and increased in 
the hippocampus. The observed mice expressed reduced response to stress, associ-
ated with releasing of corticosterone. Similar neurochemical and behavioral effects 
were not expressed in mice, who has underwent vagotomy [12, 73].
In their study Park et al. demonstrated that depressed-like behavior in mice 
that underwent bilateral olfactory bulbectomy (OBx) was associated with altered 
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colonic motility and a shift in the microbiota profile. Their experiment also sup-
posed that increased prokinetic neuropeptide, gut hormone and serotonin in the 
colonic wall are mediators of the altered motility [25]. Their finding was consistent 
with those of Rodes et al. who showed changed colonic transit and altered stability 
of the colonial microbial community [74].
Hsiao et al. demonstrated GI barrier defects and microbiota alterations in the 
maternal immune activation (MIA) mouse model who displayed ASD signs. MIA 
generation, who has received Bacteroides fragilis (human commensal microbe) per 
os, has evolved altered bacterial gut content which predisposes to impaired commu-
nication and manifestation of stereotypic, anxiety and sensorimotor behavior. The 
described experimental model showed change in profile of the serum metabolites 
and their levels. It is other evidence for the gut microbiota impact on human behav-
ior through the gut microbiome-brain functional axis and it could help in searching 
of relevant probiotic treatment of behavior disturbances in neurodevelopment 
diseases in human [3, 75].
It was found that gut microbiota status reduce social interactions in GF mice 
and probiotics improve social interactions in a post-MI rat model. Desbonnet et al. 
examined whether the degree of information transfer during social interaction is 
disrupted in GF mice. In their experiment GF mice spent a decreased proportion 
of time engaged in social investigation and substantially greater proportion of 
time engaged in repetitive self-grooming behavior during social interaction. After 
GF bacterial colonization these behaviors were normalized, which is evidence for 
involvement of microbiota in modulation of such behaviors. However, the quality 
of information transfer during the interaction was not affected in GF mice, indicat-
ing that the ability to process information per se during social interaction was not 
affected in GF mice [76].
It is important to note that many of the psychologic deficits, registered in GF 
mice, are specific to males in which higher incidence of neurodevelopmental 
disorders was registered compared to females [59, 63, 77–79]. de Theije et al. 
demonstrated that gender-specific inflammatory conditions are present in the 
small intestines of VPA in utero-exposed mice and are accompanied by a disturbed 
serotonergic system both in the brain and in the intestinal tract [80]. Gut microbi-
ota-associated behavioral changes were reported in different ASD mouse models 
using valproic acid administration or maternal infection; in the latter instance 
some behavioral disorders were favorably influenced by probiotic therapy with 
Bacteroides fragilis [8, 9].
Several studies proposed the influence of intestinal microorganisms on eating 
behavior [80], probably as a consequence of modified fatty acid receptors, gut 
receptors, responsible for taste, alteration of the intestinal transportation mecha-
nisms or disturbed releasing of satiety hormones [9, 81, 82].
Crumeyrolle-Arias et al. found that lack of intestinal microbiota in sensitive to 
stress strain rats lead to neuroendocrine and behavior reactions of acute stress and 
significant changed degree of the dopaminergic turnover in the higher brain struc-
tures which modulate stress and anxiety—another support for the crucial impact of 
the gut microbiota on the higher brain activities [9, 15, 83, 84].
Recently it was reported that impaired permeability of the blood brain barrier in 
GF mice probably will restrict reaching of the liver bacterial metabolites to the brain 
[85]. Numerous remodeling experiments in GF animals confirmed that deviations 
of brain metabolism and behavior could be preserved through reconstitution of the 
gut microbial composition [1, 86].
Wong et al. found that genetically determined caspase-1 deficit in mice suppresses 
the anxiety-depressive like behavior and improves the motor activity and locomo-
tor abilities, as well prevents manifestation of depressive symptoms after chronic 
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exposition at stressors. On the other hand, minocycline as pharmacological antagonist 
of caspase-1 alleviates the depressive like symptoms in wild type mice provoked by 
stress. Actually, both chronic stress and pharmacological inhibition of caspase-1 
modify the composition of fecal microorganisms almost in the same way [3, 87].
The GF model has some limitations, which suppose that the investigators 
should be cautious in extrapolating the conclusions obtained in animals on people. 
Important is the fact that GF mice are born under aseptic conditions, such as sepa-
ration from the mother via cesarean section and directly placement of the newborn 
in an special insulator in which the air, in which everything is sterilized, including 
the air, food and water. The biochemistry of brain and gut intestine is quite differ-
ent [1, 81], HPA axis responses [63], in emotional, [58], social [75, 79], metabolic 
function, and ingestive behaviors [82] between GF animals and control animals 
which contain normal or pathogen-free flora obtained by colonization from the 
mother [8, 78]. However, up to date studies with animal model proved that the gut 
microbiota can influence the central nervous system in the absence of substantial 
changes in local or circulating cytokines or specific intestinal neurotransmitter.
It is unambiguous that bacterial products can get access to the brain via the 
bloodstream, they can act through the immune system via cytokine releasing by 
the mucosal immune cells, or through the endocrine system by triggering gut 
hormone release from enteroendocrine cells [9, 87]. Since GF animal models are not 
analogous to the development of the human brain, premature conclusions about the 
significance of these findings to humans should be avoided [88].
5.  Findings from clinical, imaging and neurophysiological tests on the 
human brain-gut axis
Gut to brain pathways have been explored through cortical evoked potentials 
(CEPs), magnetoencephalography (MEG), positron emission tomography (PET), 
and functional magnetic resonance imaging (fMRI) [30].
Loening-Baucke et al. applied anorectal CEP in children with constipation and 
encopresis and found significantly prolonged latencies of the early-onset potentials, 
suggesting a defect in afferent pathway conduction [89].
The perception of painful stimuli is accompanied by activation of anterior 
cingulate area in people in a healthy condition, as opposite to subjects suffering 
from IBS in which activation of left prefrontal cortex occurs probably due aberrant 
CNS processing [5] Subsequent research in patients with IBS also suggest that rectal 
hypersensitivity induced by repetitive distention of the sigmoid colon correlates 
significantly with increased blood flow in the thalamus and that an aberrant 
thalamic response to pain could be the reason for the abnormal sensitization.
In studies of Ertekin et al. and Herdman et al. conducted at different times 
reproducible EMG responses on the part of external anal sphincter were evoked 
by cortical magnetoelectric stimulation. Turnbull et al. managed to differentiate 
the topographic areas of the external anal sphincter and the pelvic floor muscles 
represented at the medial side of the primary motor brain cortex using TCMS. This 
representation is bilateral and shows asymmetry in some individuals [7, 30, 90–92].
6. Effect of interventions targeting the gut microbiota
Known approach for registration the effects of intestinal microbes on brain 
function is the use self-reporting measures to determine how the brain function 
alters under the influence of induced from probiotics microbial proliferation.
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The level of anxiety and psycho-emotional stress was reduced in human (both 
male and female), treated with Lactobacillus and Bifidobacterium versus persons who 
toke control substance in a randomized placebo-control trial. However other study 
using different strain Lactobacillus does not succeed to confirm this conclusion.
But another study using a different Lactobacillus probiotic, failed to confirm 
these findings [21, 93]. The limitations in the study design including the size of the 
cohort, the mood of the surveyed contingent, the used assessment tools, the inter-
individual differences in microbial composition and the differences between the 
probiotics may be the cause of the discrepancy in the results.
Another approach is to use functional MRI (fMRI) to assess changes in the 
human brain in response to gut microbial modulation. One study showed that 
chronic ingestion of a probiotic consortium altered functional brain responses in 
healthy women [94]. In this study, the answer to the emotional face recognition 
task was measured with fMRI in healthy women before and after intake of active 
probiotic for 4 weeks, unfermented dairy product or no treatment. Women who 
were treated with probiotics demonstrated diminished response to the task of 
emotionally recognizing in extensive brain networks, including territories, respon-
sible for sensation and emotions. Self-assessment of anxiety and depression was 
not significantly different between in between the studied groups. But altered fMRI 
responses proposed a substantial change in response to emotional negative stimuli. 
Separate functional brain imaging study explored the modulatory impact of gut 
microbiota in subjects with mild cognitive impairment and hepatic encephalopathy 
through administration of non-absorbable antibacterial agent [95]. More successful 
coping with the cognitive task corresponded with increased subcortical activity 
and better frontoparietal connectivity on fMRI. Other investigation with antibiotic 
administration in people with the same diseases during 8 weeks also confirmed 
improved cognitive level and established altered serum metabolites with supposed 
bacterial origin [1, 26, 96].
7.  Role of microbiota-gut-brain axis in neurological and psychiatric 
diseases
Changes in the microbial environment, as a result of different stressors, are 
linked with alterations of barrier, motility and activation of the immune system. 
Perturbation of this axis lead to changes in the stress-response and behavior, which 
are thought to be involved in several CNS diseases, such as anxiety, depression 
autism, Parkinson’s disease and Alzheimer’s disease [97].
Neuropsychiatric comorbidity, including depression and anxiety, is common 
finding in patients with a functional GI disorder such as the IBS and it reaches 60% 
of this somatic pathology. On the other hand, IBS has also been related with changes 
in the gut microbiota including reduced diversity and temporal instability at the 
genus level. It is interesting to note that behavioral and psychological changes are 
often present in patients with active celiac disease, which are associated with find-
ings of regional cerebral hypoperfusion in their brains [25, 98].
Some recent works reported for changed expression of GABA A receptor and its 
B subunits, responsible for the primary inhibitory brain mediation [73, 99, 100], 
subunits of NMDA receptors, realizing excitatory neurotransmission [101], concen-
tration of serotonin 1A and tryptophan. Some of the above mentioned alterations 
corresponded with disturbed emotional behavior, which supports the interaction 
between microbial composition and behavior [1, 8].
In recent years evidence has emerged that neurodegenerative diseases (NDs) are 
strongly associated with the microbiome composition in the gut [101, 102].
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7.1 Role of microbiota-gut-brain axis in mood disorder
A “leaky gut” is suggested to play a pathogenic role in depression. There are 
evidences for altered intestinal permeability in patients with mood disorder and 
their first degree relatives [18]. For most of the depressed patients the brain-gut axis 
function is impaired, including imbalance in brain neurotransmitters, decline of 
brain neuroplasticity, dysfunction of hypothalamic-pituitary-adrenal axis, chronic 
periphery inflammation and neuroinflammation, as well as gastrointestinal dis-
eases and gut microbiota dysbiosis [103]. However, the impact of depression on the 
microbiota has not yet been studied [25].
Wong et al. proposed that suppression of caspase-1 plays a protective role in modu-
lation of the interaction between representatives of the intestinal microbiota and the 
state of stress. They reported the importance of signals from inflammasome along the 
gut microbiota-inflammasome-brain axis which attribute to modification of cerebral 
processes, especially for manifestation of anxiety-depressive symptoms [3, 87].
Acute tryptophan depletion (ATD) in subjects suffering from depression, was pre-
ceded by bimodal emotional processing, corresponding with bimodal manifestation 
of the clinical symptom. It was proved in a small patient’s cohort where the alleviation 
of depressive symptoms occurred 24 h after ATD and the mood processing was at 
the better level about 5 h after depletion. The opposite processes were registered in 
patients who experienced worsening of the depressive symptoms [2, 104].
Serotonin is a key element of this axis, acting as a neurotransmitter in the CNS 
and in the ENS, located in the gut wall. This transmitter is formed in neuroendo-
crine cells and plays a role of paracrine hormone in the intestine. Serotonin is also 
an endocrine hormone which passes into the blood and bind to the platelets. Besides 
its system effects like maintaining the bone density and participation in metabolite 
processes, it performs a key connection between both ends of the gut-brain axis 
[105]. It is interesting that most of the serotonin is produced at the periphery pre-
dominantly in the tGI epithelium, but also in bones, breast and pancreas. Only 5% 
of its synthesis is realized at central level. The only difference in ways of serotonin 
synthesis is the use of tryptophan hydroxylase type 1 in peripheral mechanism and 
instead of it-type 2-in the central one [105]. The reversal process of serotonin degra-
dation is performed with the help of monoamine oxidase and aldehyde dehydroge-
nase to 5HIAA both in the periphery and in the CNS [2, 96, 106].
7.1.1 Microbiota-gut-brain axis in major depression
Major depression disorder (MDD) is an incapacitating multifactorial psychiatric 
disease, which is characterized by a range of symptoms affecting both emotional 
and cognitive domains [107]. The hypothesis of activated peripheral blood mono-
cytes and T lymphocytes is well known [18]. Another supposed mechanism is 
impaired excitation/inhibition balance that is potentially mediated by the reduced 
amount of GABA. The low concentration of brain-derived neurotrophic factor has 
been proposed as a unifying hypothesis for reduced cell numbers in frontal cortex 
and amygdala and also for reduced hippocampal volume. Despite the great advances 
in the knowledge of this disease, its etiology and pathophysiology are still not fully 
understood [108].
It is important that metabolites as hippurate, dimethylamine and dimeth-
ylglycine derived from the blood of patients with MDD are actually products 
of their intestinal microbiota [109]. Similar to findings in animal experiments 
in depression, limited number of studies in humans with small cohorts found 
changes of the gut microbiota strains [25, 110]. All this trials proposed the poten-
tial relationship between the alteration of gut microbiota composition and MDD 
 manifestation [18].
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Significant difference in the isolated bacteria from stool samples of 58 Chinese 
subjects, diagnosed with major depression compared to 63 healthy individuals was 
found. Y.
The following three main bacterial phyla are specific for the gut microbiota 
of depressed subjects: Firmicutes, Actinobacteria and Bacteroidetes. Depression 
behavior models were created through transplantation of stool samples taken from 
five subjects with depression into germfree mice. And vice versa, transplantation of 
feces from five healthy individuals did not lead to behavioral effect. Mice receiving 
microbiota from patients with depression showed disturbances in hippocampal 
gene activation and also in carbohydrate and amino-acid metabolism [16, 109]. 
This study provided convincing evidence that the depressive phenotype could be 
transferred by transplantation of the microbiota.
Kelly et al. recruited 34 patients with major depression and 33 healthy individu-
als with similar demographics. Plasma levels of cytokines, C-reactive protein, 
salivary cortisol and plasma lipopolysaccharide-binding protein were determined 
by ELISA, and showed alterations supporting a proinflammatory phenotype linked 
with depression. Depression was associated with decreased gut-microbiota rich-
ness and diversity. A fecal microbiota transplant was prepared from a subgroup of 
patients with depression or from healthy individuals and transferred by oral gavage 
to a microbiota-deficient rat model [114].
But further research in larger samples and unified MDD populations is required 
to confirm whether disturbances in gut microbiota have a causative role for the 
onset of MDD.
7.2 Microbiota-gut-brain axis in autistic spectrum disorders (ASD)
During the early onset of this developmental disorder an autistic enterocolitis 
and changes in intestinal permeability occur [111]. Moreover, urinary metabolic 
phenotyping has determined biochemical changes that were consistent with abnor-
malities in the composition of the gut microbiota, found in autistic children.
Recent studies suggest that changes in antigenic load due to the impairment of 
gut barrier function is triggering factor for clinical manifestation of autism [112]. 
Desbonnet et al. are the first scientists who found that microbiota are crucial for the 
programming and presentation of distinct normal social behaviors, including social 
motivation and preference for social novelty, while also being important regula-
tors of repetitive behaviors. Taking into account that these aspects of behavior are 
impaired in neurodevelopmental disorders such as schizophrenia and autism [5] 
and with a male preponderance, these data extend our knowledge regarding the 
genesis of neurodevelopmental disorders of altered sociability. A better under-
standing of the underlying mechanisms of these social deficits, which may include 
modulation of immune cell cytokines release, changes in vagal nerve activity and 
neuroendocrine function, can help for developing of innovative and more effective 
strategies in managing of these social disturbances [76].
A study of Kang et al. revealed less abundance of Bifidobacteria species and the 
mucolytic bacterium Akkermansia muciniphila in children with autism [114–116]. 
Other experiment showed less diverse gut microbial composition with lower levels 
of Prevotella, Coprococcus, and unclassified Veillonellaceae in ASD [117]. Another 
study showed a significant increase in several mucosa-associated Clostridiales, 
whereas a decrease in Dorea, Blautia and Sutterella was seen in AUTISM-FGID [118].
7.3 Microbiota-gut-brain axis in Alzheimer disease
Alzheimer disease is a progressive neurodegenerative illness associated with 
accumulation of proteinaceous misfolded amyloid-b (Ab) fibrils and oligomers, 
Behavioral Neuroscience
14
together with neurofibrillary tangles consisting of hyperphosphorylated tau protein 
in the cerebral cortex and other brain regions [118]. Recent research indicates that 
alterations of the gut microbiome could activate proinflammatory cytokines and 
increase intestinal permeability, leading to insulin resistance, which has also been 
found in AD [119].
Bacterial representatives of the gut microbiome excrete lipopolysaccharides 
(LPSs) and amyloids. These products lead to forceful pro-inflammatory and innate-
immune effects, activate the system Following enhanced amyloid aggregation, as 
well secondary degeneration occur, which are typical signs of AD, together with 
impaired cleansing mechanisms of Aβ peptide [17, 120, 121]. It has been suggested 
that diet and specific nutrients could alert the composition of the intestinal micro-
biota and might influence the production or aggregation of amyloid proteins [29, 
114, 122].
7.4 Microbiota-gut-brain axis in Parkinson disease and its prodromes
Currently it is well established that Parkinson’s disease (PD) is not a pure move-
ment disorder of the CNS but also a gastrointestinal disease [115–117], which affects 
the ENS [123–125]. The main premotor PD symptoms include rapid eye movement 
sleep behavior disorder, hyposmia, constipation and depression [126].
Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia 
which results from the loss of physiological motor inhibition and is manifested with 
abnormal behavior during REM sleep. That disorder leads to varying degrees of 
complex motor activity which ranges from sleep talking to violent dream enacting 
behaviors potentially harmful for the subject or bed partner [127, 133].
In their study Heintz-Buschart et al. revealed differential abundances of gut 
microbial taxa (such as Akkermansia) in Parkinson disease (PD) and its prodromal 
state idiopathic REM sleep behavior disorder compared to healthy controls. The 
majority (about 80%) of the differential gut strains in patients with PD are very 
similar to those in subjects with idiopathic REM sleep behavior disorder. Most com-
mon are Anaerotruncus and Bacteroides, which correspond to non-motor symptoms 
of the disorders. Metagenomic sequencing of specific microbial samples allows the 
genomic reconstruction [23, 128]. Other studies registered reduction of microor-
ganisms as Faecalibacterium, Coprococcus, Blautia, Prevotella and Prevotellaceae in 
gut of subjects, suffering from PD. These alterations are non-disease specific at a 
lower taxonomic level, for example at phylum stage, but at higher taxonomic level 
as genus or species, was registered some overlap between alpha synucleinopathies 
such as PD and multisystem atrophy (MSA) [3, 102].
It has been shown that PD patients with RBD exhibit much higher frequencies 
of phosphorylated asyn pathology in the colon and in the skin compared to PD 
patients without RBD [129]. Also, idiopathic RBD subjects exhibit marked pathol-
ogy in the sympathetic and parasympathetic nervous system, but a relatively intact 
dopamine system [130].
For Prevotella such reduction has also been observed in RBD patients. Based on 
the attributed functional properties of these bacteria, such alterations could affect 
gut barrier integrity, short-chain fatty acid (SCFA) production, and inflammation. 
This would be in line with reports of a leaky gut and reduced levels of SCFAs and 
lipopolysaccharide binding protein in PD patients.
An interesting link between gut microbiota and asyn pathology could be 
cross-seeding of amyloid pathology induced by bacterial amyloid proteins such as 
curli.
So far, human microbiome studies in PD have been carried out exclusively in 
medicated patients, except for one study that included also idiopathic RBD patients 
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[131]. While the PD associated microbiome alterations have been confirmed in 
drug adjusted analyses, confounding effects which could be result of COMT inhibi-
tors intake cannot be excluded. Another potential confounder is colonic dysmotil-
ity, which may independently alter microbiota composition [132, 133].
Thus, observed brain and behavioral changes may be mediated by the absence 
of intestinal microbes directly or indirectly through one or more of the non-brain-
related alterations. The latest data show that the intrauterine environment is not 
sterile, and it can even be supposed that microbial metabolites of the intestine from 
the maternal microbes of the intestine may have an effect on the development of 
the fetal brain [75]. The altered signaling of the cecum to the brain secondary to the 
massive cecal dilation associated with this model may alter the development of the 
brain regions that process this input [88].
8. Discussion
The gut microbiota has co-evolved with its host for millennia and influences 
positively many functions of the host organism, as digestion, production of nutri-
ents, detoxification, defense against pathogens and immune regulations [2, 3, 123].
As a key component of the gut brain, gut microbiota influences the development and 
maturation of the HPA axis [134], affects the development and function of the immune 
system [135], regulates the blood-brain barrier [136], modulates the synthesis and 
recognition of neurotransmitters [73], regulates neurogenesis, formation of myelination 
[137], and supports the development and function of the brain [78]. Microbiota-gut-
brain axis plays a crucial role for manifestation of mental disorders [103].
Following the development of gut microbiota, the scientists not only focus on 
the top-down effects of the brain-gut axis (from brain to gut), but they also devote 
special attention to the bottom-up influences (from gut to brain) [138]. Alterations 
of the “gut brain” as pathological changes of intestinal microbiota affect the brain 
activity and have an impact on behavior. In turn, the emerging brain changes 
provide feedback on the gut. Uniting the brain and the colon, the brain as targeting 
gut microbiota organ is becoming a key trend in neuroscience and reliable field for 
successful management of neuropsychological disorders [11, 103].
Treatment with antidepressants has achieved a significant improvement from 
the introduction of selective serotonin re-uptake inhibitors and rather the intro-
duced serotonin and noradrenaline re-uptake inhibitors, however, there are still 
outstanding clinical requirements for the treatment of depression, and better thera-
peutic strategies are needed, especially with regard to the treatment of depressive 
cure and additional comorbid painful physical conditions such as GI discomfort [5]. 
There are confirmations for intestinal microbe changes in patients suffering from 
major depression [114, 139], as well as in IBS. Considering the serious evidence 
from laboratory animal models in which the stress affects brain-gut-microbial axis, 
this area requires more research in humans. In addition to the effects on the immune 
system, probiotics have also been shown to improve carbohydrate malabsorption 
[140], which in turn is associated with both early signs of depression and reduced 
levels of tryptophan [141].
There is a reasonable assumption that probiotic treatment can produce a 
beneficial effect on mood by raising serotonin precursor levels, tryptophan, and 
hence increasing serotonin availability [5]. Despite these promising initial find-
ings on microbiota and stress-related disorders, there is a relative lack of research 
among healthy individuals linking the composition and function of the microbes 
inhabiting the human intestine and levels of chronic stress or susceptibility to 
acute stress [26].
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Studies in animal models are crucial for guiding research on brain-gut 
microbiome-axis in humans, as the impact of microbiota on specific brain regions 
and aspects of animal behavior will help in the selection of tasks for cognitive 
assessment. Such studies will also be useful in identifying which bacteria may 
be of particular importance. For example, in rodent models, a specific strain of 
Bifidobacterium longum was found to alter cognition, [142], as well as stress-related 
behavior and physiology, and a similar effect profile was subsequently observed in 
people given this strain [26, 143].
Recent research indicates that the gut microbiota is associated with health in the 
elderly, with those in long-term care having a less diverse microbiota than those liv-
ing in the community [144]. Even in healthy aging, some aspects of cognition could 
be deteriorated. Despite the growing interest in this problem, there is still lack of 
sufficient studies, especially of long-term longitudinal research examining changes 
in the human gut microbiota with aging. The high inter-individual variation in 
the gut microbiota also impedes interpretation. Such research efforts should occur 
in the context of rapid acceleration of genetic sequencing technologies for better 
characterizing of the gut microbiota [26, 145].
We are witnesses of extraordinary merging of research approaches in different 
areas of psychiatry, gastroenterology and neurology which significantly improve 
our understanding of neuropsychiatric diseases and more clearly explain the close 
relationship between GI and mood disorders. As a result the therapeutic strategies 
in some mental illnesses significantly advanced. For example, IBS, recognized 
as linked with psychosocial and GI disorders [6, 146] and often accompanied by 
depressive symptoms [147, 148] has improved since introduction of an interdisci-
plinary approach [5]. Although the brain and gut are organs with quite different 
functions at first glance, the emerging part of the scientific sources provides proofs 
for their synergy along the “brain and gut axis” and suppose that not only the brain 
may affect the intestinal function but also the gut, both by direct and by indirect 
mechanisms can cause alterations in CNS [6, 149], and in stress-related disorders 
such as depression [5].
It is not known whether the observed changes in the microbiome play a causal 
role in the development of the intestinal pathology in PD or whether they are a 
consequence of the altered intestinal function. However, observations that motor 
symptoms, neuroinflammation, asyne pathology and intestinal motility may be 
modulated by manipulation of the gut microbes in transgenic asyne-overexpressing 
mice suggest that such causative effects are possible [150, 151].
In order to establish which mechanisms connect microbe alterations and PD, 
such studies should use a multiomics approach, including meta-genomic, metatran-
scriptional and metabolomic assays, in combination with assessment of host factors 
such as intestinal biopsy, permeability studies, cytokine levels and host genotype. 
For this purpose multi-center consortia need to cooperate to ensure a sufficient 
cohort size and standardized methodology [132].
A fuller understanding of the human “hologenome,” of human microbial 
ecosystems and their secretory products should provide a deeper insight into their 
contribution to age-related neurological diseases associated with amyloidogenesis, 
CNS inflammation and progressive neurodegeneration [120].
It is suggested that modulating the gut microbiome through specific nutritional 
interventions and the use of prebiotics and probiotics might represent an effective 
strategy to reduce the level of chronic inflammation and Ab associated with AD, 
possibly preventing or ameliorating AD symptoms [29].
A deeper understanding of how psychological development and social and cul-
tural factors affect the brain-gut-microbiome axis will contextualize the role of this 
axis in humans and give a light on the necessary psychological interventions that 
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will improve the health of the brain-gut-microbiome axis. Interventions apparently 
aimed at alleviating disorders in a part of the brain-intestinal-microbial axis (e.g., 
depression psychotherapy) may still affect other parts of the axis (e.g., microbial 
composition and function) and functional GI disorders such as IBS are disorder of 
the axis, not an isolated problem of both psychology and gastrointestinal function. 
Discipline psychology should be aware of these interactions in order to help create a 
future research program in this emerging research area [26, 152].
9. Conclusion
The gut microbiota influences the brain biochemistry and hence—the behavior 
irrespective of the autonomic nervous system, specific GI neurotransmitters, or 
inflammation. The intestinal commensals communicate with the human body via 
immune, endocrine and neural mechanism. These functional pathways are part 
of the microbiota- gut-brain-axis and according to preclinical evidence the gut 
microbes can recruit the above mentioned bidirectional communication relation-
ship to modulate not only the brain development and functioning, but also our 
behavior. Disruption of gut-brain axis function is associated with alterations in the 
stress response and might contribute to neuropsychiatric diseases as mood disorder, 
ASD, REM sleep behavior disorder, Parkinson disease, Alzheimer disease and other 
mental conditions. Exploring the interaction of gut microbes and human brain will 
not only allow us to better understand the pathogenesis of neuropsychiatric disor-
ders, but will also provide us new opportunities for the design of novel immuno- or 
microbe-based therapies.
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